InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Stock Elyse, Directeur Médical. Director active across 1 company, notably Biohaven Pharmaceutical Holding Co Ltd.. In total, 8 disclosures have been recorded. History available since 25 November 2021. The latest transaction was filed on 10 January 2022 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
937 shares0Common SharesSEC:0001562180-22-000439
937 shares0Common SharesSEC:0001562180-22-000439:0
3,750 shares0Common SharesSEC:0001562180-22-000352
3,750 shares0Common SharesSEC:0001562180-22-000352:0
3,362 shares@ US$20.790.0047% mcap100.0% of flowCommon SharesSEC:0001562180-21-007738
3,362 shares@ US$20.790.0047% mcap50.0% of flowCommon SharesSEC:0001562180-21-007738:0
3,375 shares0Common SharesSEC:0001562180-21-007303:0
3,375 shares0Common SharesSEC:0001562180-21-007303
8 of 8 declarations
About Stock Elyse
Stock Elyse is the Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd. In this role, she oversees the company's medical and clinical initiatives. Her expertise in the pharmaceutical field is essential for developing new treatments and ensuring patient safety. She plays a key role in guiding the strategic direction of Biohaven's medical projects.
